<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/uthr" ></link>
<id>urn:uuid:dfb6340f-6ffe-dc84-0c9d-a212db4ec54e</id>
<updated>2026-07-01T19:08:29-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>UTHR: ROTHBLATT MARTINE A (CEO,DIR) Exercised 9,500 Options (OE) of UNITED THERAPEUTICS CORP for $135.42 on 6/30, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/uthr/united-therapeutics-corp/id-6434984" ></link>
<id>urn:uuid:fa172d57-5952-4f8d-e4e3-751e1ac0476c</id>
<updated>2026-07-01T16:31:14-04:00</updated>
<summary type="html" ><![CDATA[UNITED THERAPEUTICS CORP (UTHR). Recent Price: $542.66. Mkt Cap:23.0B. 10D Vol: 715,370]]></summary>
</entry>
<entry>
<title>UTHR: ROTHBLATT MARTINE A (CEO,DIR) Exercised 9,500 Options (OE) of UNITED THERAPEUTICS CORP for $135.42 on 6/29, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/uthr/united-therapeutics-corp/id-6434210" ></link>
<id>urn:uuid:b4956a70-f90d-fe2b-1179-f003dc58a6a0</id>
<updated>2026-06-30T16:40:22-04:00</updated>
<summary type="html" ><![CDATA[UNITED THERAPEUTICS CORP (UTHR). Recent Price: $542.66. Mkt Cap:23.0B. 10D Vol: 715,370]]></summary>
</entry>
<entry>
<title>UTHR: ROTHBLATT MARTINE A (CEO,DIR) Exercised 9,500 Options (OE) of UNITED THERAPEUTICS CORP for $135.42 on 6/26, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/uthr/united-therapeutics-corp/id-6433533" ></link>
<id>urn:uuid:dbd2fbc8-5fb4-db79-c590-85e86f4c169b</id>
<updated>2026-06-29T16:33:59-04:00</updated>
<summary type="html" ><![CDATA[UNITED THERAPEUTICS CORP (UTHR). Recent Price: $542.66. Mkt Cap:23.0B. 10D Vol: 715,370]]></summary>
</entry>
<entry>
<title>UTHR: ROTHBLATT MARTINE A (CEO,DIR) Exercised 9,500 Options (OE) of UNITED THERAPEUTICS CORP for $135.42 on 6/25, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/uthr/united-therapeutics-corp/id-6432972" ></link>
<id>urn:uuid:f5e106ce-b2c4-621f-40a4-bc0715c8f4dc</id>
<updated>2026-06-26T16:32:35-04:00</updated>
<summary type="html" ><![CDATA[UNITED THERAPEUTICS CORP (UTHR). Recent Price: $542.66. Mkt Cap:23.0B. 10D Vol: 715,370]]></summary>
</entry>
<entry>
<title>UTHR: ROTHBLATT MARTINE A (CEO,DIR) Exercised 9,500 Options (OE) of UNITED THERAPEUTICS CORP for $135.42 on 6/24, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/uthr/united-therapeutics-corp/id-6432421" ></link>
<id>urn:uuid:39c3d407-b85f-e08f-18c9-cd5f5bbd604d</id>
<updated>2026-06-25T16:39:50-04:00</updated>
<summary type="html" ><![CDATA[UNITED THERAPEUTICS CORP (UTHR). Recent Price: $542.66. Mkt Cap:23.0B. 10D Vol: 715,370]]></summary>
</entry>
</feed>